English (United Kingdom)German formal - Sie Greek
Home Τα νέα μας
Font Size Larger Font Smaller Font

An Exciting New Treatment Option

Please check this section frequently for updates on news announcements, industry events, and for our latest media resources.

Upcoming Events

British and Eire Association of Vitreoretinal Surgeons (BEAVRS)
November 7-8, 2013 | Bristol, England

American Academy of Ophthalmology 2013 Annual Meeting (AAO)
November 16-19, 2013 | New Orleans, LA USA
Oraya Therapeutics Booth #2363 Hall F

Latest Press Releases

Wednesday, September 25, 2013 | Oraya Therapeutics, Inc. announced today the two-year results of its INTREPID study of Oraya Therapy™ Stereotactic Radiotherapy for the treatment of wet age-related macular degeneration (AMD)…More >

Wednesday, August 14, 2013 | Oraya Therapeutics, Inc. announced today that the Oraya Therapy™ Stereotactic Radiotherapy for the treatment of wet age-related macular degeneration (AMD) is now available at Optegra Manchester Eye Hospital…More >

Thursday, April 18, 2013 | Oraya Therapeutics, Inc. today announced that results of its INTREPID study evaluating the safety and efficacy of Oraya Therapy™ Stereotactic Radiotherapy…More >

Thursday, April 4, 2013 | New Therapy for Wet AMD Introduced in Switzerland by Oraya® Therapeutics and EyeRAD…More >

Latest News

October 2, 2013 | eyewireTV Weekly
Two-year results of Oraya Therapeutics’ INTREPID study are presented, showing that radiation therapy for wet AMD is safe and effective.

September 25, 2013 | eyewireToday
Oraya Therapeutics INTREPID Study Demonstrates 2-year Safety and Effectiveness of Non-invasive Therapy for Wet AMD.

September 2013 | EUROTIMES Seminar Supplement 12th EURETINA Congress
Oraya Therapy – A Significant Advance in the Treatment of Wet AMD

September 30, 2013 | CHOICE
X-ray Aid For Eyes

September 30, 2013 | Readers Digest
This Won’t Hurt A Bit

June/July, 2013 | Vision Magazine, Issue 60
Radiotherapy breakthrough to treat wet AMD

April 18, 2013 | The Wall Street Journal
Oraya Therapeutics’ INTREPID Study Published in Ophthalmology, the Official Journal of the American Academy of Ophthalmology

April 1, 2013 | New Retina MD
Radiation Therapy for Neovascular Age-related Macular Degeneration

March 4, 2013 | Mail Online
The X-ray beam that could end painful jabs for aging eyes

March 1, 2013 | Ophthalmology Times
INTREPID identifies ‘best responders’: Fewer anti-VEGF injections among benefits of stereotactic radiotherapy for wet AMD

February 27, 2013 | Insight Radio
Revolutionary Treatment for AMD Launched

February 26, 2013 | Yahoo!7 News
Hope for eye disease sufferers

February 25, 2013 | ITV
New hope for macular degeneration

February 11, 2013 | SMT Online
OnCore Opens Medical Center-of-Excellence

Presented at 2012 AAO-APAO Joint Meeting
IRay Plus Anti-VEGF Treatment for Patients with Wet Age-Related Macular Degeneration: The INTREPID Trial of Stereotactic Radiotherapy for Choroidal Neovascularization in AMD
Peter K. Kaiser, MD View Video >